Shameek Konar 13D/13G Filings for Ernexa Therapeutics Inc. (ERNA)

Shameek Konar 13D and 13G filings for Ernexa Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-15
4:42 pm
Purchase
2025-03-3113GErnexa Therapeutics Inc.
ERNA
Shameek Konar229,020
5.500%
229,020increase
(New Position)
Filing